专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5760514A Assembly for one-way clutch, with outer ring and stator shaped so as to reduce effects of thermal shrinkage 失效
标题翻译：用于单向离合器的组装，外圈和定子成形，以减少热收缩的影响
公开(公告)号：US5760514A
公开(公告)日：1998-06-02
申请号：US738163
申请日：1996-10-25
申请人： Toshio Taniguchi , Masanori Arima , Masanobu Umezawa , Katsumi Sekine
发明人： Toshio Taniguchi , Masanori Arima , Masanobu Umezawa , Katsumi Sekine
IPC分类号： F16H41/24 , F16D41/06
CPC分类号： F16H41/24 , F16H2041/246
摘要： The present invention is intended to provide a one-way clutch capable of preventing the inner circumferential surface of the outer ring of the one-way clutch from being deformed even when the outer ring of the one-way clutch for a stator constituting a torque converter is integrally formed with the stator made of plastic. To attain the object, in the one-way clutch for the plastic stator, wherein the bearing support portion of the stator is integrally formed in the inner circumferential direction at or near one axial end of the boss portion of the stator and the outer ring is inserted in and formed on the inner circumferential side of the boss portion so as to be integrally held, the thickness of the outer ring on the side opposite to the bearing support portion is made smaller than that on the side of the bearing support portion, or the outer diameter of the outer ring is gradually decreased in the axial direction from the end of the outer ring on the side of the bearing support portion to the other end, or a ring-shaped step portion is provided at the other axial end on the outer circumferential surface of the outer ring so that the amount of thermal shrinkage at the plastic portion on the side of the bearing support portion of the stator is made almost equal to the thermal shrinkage at the plastic portion on the opposite side.
摘要翻译：本发明旨在提供一种单向离合器，其能够防止单向离合器的外圈的内周面变形，即使构成变矩器的定子用单向离合器的外圈与由塑料制成的定子一体形成。为了实现该目的，在用于塑料定子的单向离合器中，其中定子的轴承支撑部分在内周方向上在定子的凸台部分的一个轴向端处或附近一体地形成，并且外圈是插入并形成在凸台部的内周侧上以一体地保持，使外圈的与轴承支撑部相对的一侧的厚度小于轴承支撑部侧的厚度，或者外圈的外径在轴承方向上从轴承支承部侧的端部向轴向方向逐渐减小，另一端的另一方的轴向端部设置有环状台阶部外圈的外周面，使得定子的轴承支撑部侧的塑料部的热收缩量几乎等于塑料波的热收缩在对面。

2. 发明申请

US20100158996A1 ESTER COMPOUND AND MEDICAL USE THEREOF 审中-公开
标题翻译：酯化合物及其医药用途
公开(公告)号：US20100158996A1
公开(公告)日：2010-06-24
申请号：US12627535
申请日：2010-02-12
申请人： Atsushi Hagiwara , Yasuhiro Ohe , Naoya Odani , Shizue Watanabe , Taku Ikenogami , Takashi Kawai , Kenya Madono , Toshio Taniguchi
发明人： Atsushi Hagiwara , Yasuhiro Ohe , Naoya Odani , Shizue Watanabe , Taku Ikenogami , Takashi Kawai , Kenya Madono , Toshio Taniguchi
IPC分类号： A61K31/5375 , C07C229/40 , A61K31/24 , C07C69/76 , A61K31/235 , C07D213/55 , A61K31/44 , C07D277/20 , A61K31/426 , C07D213/56 , A61K31/4406 , C07D211/60 , A61K31/4453 , C07D295/00 , C07D209/04 , A61K31/404 , C07D235/12 , A61K31/4184 , C07D263/58 , A61K31/421 , A61K31/35 , A61K31/40 , A61K31/4188 , A61K31/337 , A61K38/28 , A61K9/48 , A61P3/06 , A61P9/10 , A61P3/04 , A61P9/12
CPC分类号： C07D207/404 , A61K31/215 , A61K31/216 , A61K31/235 , A61K31/24 , A61K31/245 , A61K31/277 , A61K31/381 , A61K31/397 , A61K31/40 , A61K31/4015 , A61K31/404 , A61K31/4184 , A61K31/423 , A61K31/426 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61K31/4453 , A61K31/4468 , A61K31/5375 , C07C69/732 , C07C69/76 , C07C69/88 , C07C233/81 , C07C235/06 , C07C235/14 , C07C235/16 , C07C235/26 , C07C235/30 , C07C235/34 , C07C235/40 , C07C235/64 , C07C235/84 , C07C237/42 , C07C311/04 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2603/18 , C07D205/12 , C07D207/09 , C07D207/16 , C07D209/08 , C07D211/58 , C07D213/55 , C07D213/61 , C07D213/82 , C07D235/06 , C07D263/58 , C07D277/30 , C07D277/56 , C07D295/135 , C07D295/192 , C07D333/24
摘要： A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1″) (wherein R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; X is —COO— or —CON(R10)—; R3 and R4 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R9 and R9 are each independently hydrogen atom, C1-C6 alkyl, —CON(R18) (R19) or —COO(R20), etc.; ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; Alk1 and Alk2 are each independently alkanediyl, etc.; l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.
摘要翻译：作为高脂血症的新型治疗剂，其是由式（1“）表示的酯化合物（其中R 1和R 2各自为氢原子或任选取代的芳基等; X为-COO-或-CON（R 10） - ; R 3和R 4各自为氢原子，C 1 -C 6烷基或C 1 -C 6烷氧基等; R 5，R 6和R 7各自为氢原子，C 1 -C 6烷基或C 1 -C 6烷氧基等; R 9和R 9各自独立地为氢原子，C1-C6烷基，-CON（R18）（R19）或-COO（R20）等;环A，环B和环C各自独立地为芳基或杂环残基等; Alk1和Alk2分别为独立的烷二基等; l和m各自为0或1〜3的整数）或其前药，或其药学上可接受的盐。治疗剂选择性地抑制小肠中的MTP，因此不会引起脂肪肝的副作用。

3. 发明授权

US07157731B2 Semiconductor device and its manufacture 有权
标题翻译：半导体器件及其制造
公开(公告)号：US07157731B2
公开(公告)日：2007-01-02
申请号：US10707525
申请日：2003-12-19
申请人： Toshio Taniguchi , Taiji Ema , Toru Anezaki
发明人： Toshio Taniguchi , Taiji Ema , Toru Anezaki
IPC分类号： H01L21/00
CPC分类号： H01L21/823814 , H01L21/823842 , H01L21/82385 , H01L21/823864 , H01L27/1052 , H01L27/10814 , H01L27/10873 , H01L27/10894 , H01L29/6659 , H01L29/7833
摘要： In a logic area, impurities are doped into the gate electrode and the source/drain diffusion regions of a MIS transistor. Thereafter in a memory cell area, word lines are patterned, source/drain regions are formed, and contact holes are formed. Side wall spacers of the MIS transistor in the logic area are made of silicon oxide. A semiconductor device of logic-memory can be manufactured by a reduced number of manufacture processes while the transistor characteristics are stabilized and the fine patterns in the memory cell are ensured.
摘要翻译：在逻辑区域中，杂质掺杂到MIS晶体管的栅电极和源极/漏极扩散区域中。此后，在存储单元区域中，对字线进行构图，形成源极/漏极区域，形成接触孔。逻辑区域中的MIS晶体管的侧壁间隔物由氧化硅制成。可以通过减少数量的制造工艺来制造逻辑存储器的半导体器件，同时晶体管特性被稳定并且确保了存储器单元中的精细图案。

4. 发明申请

US20060089392A1 Ester derivatives and medicinal use thereof 有权
标题翻译：酯衍生物及其药用
公开(公告)号：US20060089392A1
公开(公告)日：2006-04-27
申请号：US11250636
申请日：2005-10-17
申请人： Atsushi Hagiwara , Taku Ikenogami , Kazunori Kurihara , Toshio Taniguchi , Mitsuru Takahashi , Akio Ida
发明人： Atsushi Hagiwara , Taku Ikenogami , Kazunori Kurihara , Toshio Taniguchi , Mitsuru Takahashi , Akio Ida
IPC分类号： A61K31/455 , A61K31/4245 , A61K31/235 , C07C237/40
CPC分类号： C07D295/192 , C07C237/42 , C07C255/55
摘要： The present invention relates to an ester represented by the formula [1]: or its pharmaceutically acceptable salt, or use of the same. The compound represented by the formula [1] or its pharmaceutically acceptable salt is useful as an agent for the treatment or prophylaxis of hyperlipidemia or the like, since it disappears very rapidly in the living body and has an excellent MTP inhibitory activity.
摘要翻译：本发明涉及由式[1]表示的酯：或其药学上可接受的盐或其用途。由式[1]表示的化合物或其药学上可接受的盐可用作治疗或预防高脂血症等的药剂，因为其在生物体中消失非常迅速，具有优异的MTP抑制活性。

5. 发明申请

US20050059810A1 Dibenzylamine compound and medicinal use thereof 有权
标题翻译：二苄胺化合物及其药用
公开(公告)号：US20050059810A1
公开(公告)日：2005-03-17
申请号：US10503185
申请日：2003-08-29
申请人： Kimiya Maeda , Hironobu Nagamori , Hiroshi Nakamura , Hisashi Shinkai , Yasunori Suzuki , Daisuke Takahashi , Toshio Taniguchi
发明人： Kimiya Maeda , Hironobu Nagamori , Hiroshi Nakamura , Hisashi Shinkai , Yasunori Suzuki , Daisuke Takahashi , Toshio Taniguchi
IPC分类号： A61P3/04 , A61P3/06 , A61P9/10 , A61P43/00 , C07C229/46 , C07C255/58 , C07D213/74 , C07D231/38 , C07D239/42 , C07D249/14 , C07D257/06 , C07D261/14 , C07D263/48 , C07D271/06 , C07D271/07 , C07D271/10 , C07D275/02 , C07D277/42 , C07F5/00 , C07C211/30 , C07C255/50
CPC分类号： C07D213/74 , C07C229/46 , C07C255/58 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07D231/38 , C07D239/42 , C07D249/14 , C07D257/06 , C07D261/14 , C07D263/48 , C07D271/07 , C07D271/10 , C07D275/02
摘要： A dibenzylamine compound represented by the formula (1) wherein R1 and R2 are each a C1-6 alkyl group optionally substituted by halogen atoms and the like; R3, R4 and R5 are each a hydrogen atom, a halogen atom and the like, or R3 and R4 may form, together with carbon atoms bonded thereto, a homocyclic or heterocyclic ring optionally having substituent(s); A is —N(R7) (R8) and the like; ring B is an aryl group or a heterocyclic residue; R6 is a hydrogen atom, a halogen atom, a nitro group, a C1-6 alkyl group and the like; n is an integer of 1 to 3, a prodrug thereof and a pharmaceutically acceptable salt thereof show selective and potent CETP inhibitory activity, and therefore, they can be provided as therapeutic or prophylactic agents for hyperlipidemia or arteriosclerosis and the like.
摘要翻译：由式（1）表示的二苄胺化合物，其中R 1和R 2各自为任选被卤素原子等取代的C 1-6烷基; R 3，R 4和R 5各自为氢原子，卤素原子等，或者R 3和R 4可以与其键合的碳原子一起形成稠环或任选具有取代基的杂环; A是-N（R 7）（R 8）等; 环B是芳基或杂环残基; R 6是氢原子，卤原子，硝基，C 1-6烷基等; n为1〜3的整数，其前药及其药学上可接受的盐具有选择性且有效的CETP抑制活性，因此可作为高脂血症或动脉硬化等的治疗剂或预防剂使用。

6. 发明授权

US07598704B2 Print system and print terminal, and image saving system and image saving unit 有权
标题翻译：打印系统和打印终端，以及图像保存系统和图像保存单元
公开(公告)号：US07598704B2
公开(公告)日：2009-10-06
申请号：US11333305
申请日：2006-01-18
申请人： Toshio Taniguchi , Toshio Matsubara
发明人： Toshio Taniguchi , Toshio Matsubara
IPC分类号： H02J7/00
CPC分类号： H02J7/025 , H02J50/12 , H04M1/7253
摘要： As the present invention is adapted to receive an image to be printed or to be saved from a portable device having the image by wireless communication, an image needs not to be passed via a memory card or by connector connection or the like. As the present invention is also adapted to automatically identify the other party's device to wirelessly communicate with and establish a channel, and further adapted to supply power to the other party's device without contact, it is advantageous that a battery of the portable device is not exhausted or the portable device is not disconnected even if the device communicates wirelessly for a long time.
摘要翻译：由于本发明适于通过无线通信从具有图像的便携式设备接收要打印或被保存的图像，所以不需要通过存储卡或连接器连接等传递图像。由于本发明还适于自动识别另一方的设备以与无线通信并建立通道，并且还适于在不接触的情况下向另一方的设备供电，有利的是便携式设备的电池未被耗尽或者即使设备长时间无线通信，便携式设备也不会断开连接。

7. 发明授权

US06690050B2 Semiconductor device and its manufacture 有权
标题翻译：半导体器件及其制造
公开(公告)号：US06690050B2
公开(公告)日：2004-02-10
申请号：US09571555
申请日：2000-05-16
申请人： Toshio Taniguchi , Taiji Ema , Toru Anezaki
发明人： Toshio Taniguchi , Taiji Ema , Toru Anezaki
IPC分类号： H01L27108
CPC分类号： H01L21/823814 , H01L21/823842 , H01L21/82385 , H01L21/823864 , H01L27/1052 , H01L27/10814 , H01L27/10873 , H01L27/10894 , H01L29/6659 , H01L29/7833
摘要： In a logic area, impurities are doped into the gate electrode and the source/drain diffusion regions of a MIS transistor. Thereafter in a memory cell area, word lines are patterned, source/drain regions are formed, and contact holes are formed. Side wall spacers of the MIS transistor in the logic area are made of silicon oxide. A semiconductor device of logic-memory can be manufactured by a reduced number of manufacture processes while the transistor characteristics are stabilized and the fine patterns in the memory cell are ensured.
摘要翻译：在逻辑区域中，杂质掺杂到MIS晶体管的栅电极和源极/漏极扩散区域中。此后，在存储单元区域中，对字线进行构图，形成源极/漏极区域，形成接触孔。逻辑区域中的MIS晶体管的侧壁间隔物由氧化硅制成。可以通过减少数量的制造工艺来制造逻辑存储器的半导体器件，同时晶体管特性被稳定并且确保了存储器单元中的精细图案。

8. 发明授权

US06204167B1 Method of making a multi-level interconnect having a refractory metal wire and a degassed oxidized, TiN barrier layer 有权
$Method of making a multi-level interconnect having a refractory metal wire and a degassed oxidized, TiN barrier layer$
标题翻译：制造具有难熔金属线和脱气氧化的TiN阻挡层的多层互连的方法
公开(公告)号：US06204167B1
公开(公告)日：2001-03-20
申请号：US09159601
申请日：1998-09-24
申请人： Toshio Taniguchi
发明人： Toshio Taniguchi
IPC分类号： H01L214763
CPC分类号： H01L23/53257 , H01L23/53223 , H01L2924/0002 , Y10S438/927 , H01L2924/00
摘要： A multi-level wiring structure having: a first wiring formed on an insulating surface, the first wiring containing refractory metal as a main composition thereof; an inter-level insulating film formed to cover the first wiring and having a contact hole at a predetermined region of the first wiring; a second wiring formed over said inter-level insulating film to be electrically connected to an upper surface of the first wiring at a region of the contact hole, the second wiring containing Al as a main composition thereof; and a barrier layer disposed at an interface where the first and second wirings are electrically connected, the barrier layer being made of a material different from, and substantially not reacting with, both Al and the refractory metal constituting the main composition of the first wiring. It is possible to suppress an increase of contact resistance between an upper level wiring and a lower level wiring even if refractory metal is used as the lower level wiring and heat treatment is performed after the upper level wiring is formed.
摘要翻译：一种多级布线结构，具有：形成在绝缘表面上的第一布线，所述第一布线包含难熔金属作为其主要组成; 形成为覆盖所述第一布线并且在所述第一布线的预定区域具有接触孔的层间绝缘膜; 形成在所述层间绝缘膜上的第二布线，以在所述接触孔的区域电连接到所述第一布线的上表面，所述第二布线以Al为主要成分; 以及阻挡层，其设置在所述第一和第二布线电连接的界面处，所述阻挡层由与构成所述第一布线的主要组成的所述难熔金属不同且基本上不反应的材料制成。即使使用难熔金属作为下层布线，也可以抑制上层布线和下层布线之间的接触电阻的增加，并且在形成上层布线之后进行热处理。

9. 发明授权

US08101774B2 Ester derivatives and medicinal use thereof 有权
标题翻译：酯衍生物及其药用
公开(公告)号：US08101774B2
公开(公告)日：2012-01-24
申请号：US11250636
申请日：2005-10-17
申请人： Atsushi Hagiwara , Taku Ikenogami , Kazunori Kurihara , Toshio Taniguchi , Mitsuru Takahashi , Akio Iida
发明人： Atsushi Hagiwara , Taku Ikenogami , Kazunori Kurihara , Toshio Taniguchi , Mitsuru Takahashi , Akio Iida
IPC分类号： C07D213/56 , A61K31/44
CPC分类号： C07D295/192 , C07C237/42 , C07C255/55
摘要： The present invention relates to an ester represented by the formula [1]: or its pharmaceutically acceptable salt, or use of the same. The compound represented by the formula [1] or its pharmaceutically acceptable salt is useful as an agent for the treatment or prophylaxis of hyperlipidemia or the like, since it disappears very rapidly in the living body and has an excellent MTP inhibitory activity.
摘要翻译：本发明涉及由式[1]表示的酯：或其药学上可接受的盐或其用途。由式[1]表示的化合物或其药学上可接受的盐可用作治疗或预防高脂血症等的药剂，因为其在生物体中消失非常迅速，具有优异的MTP抑制活性。

10. 发明授权

US07807701B2 Dibenzylamine compounds and pharmaceutical use thereof 有权
标题翻译：二苄胺化合物及其药物用途
公开(公告)号：US07807701B2
公开(公告)日：2010-10-05
申请号：US11939359
申请日：2007-11-13
申请人： Kimiya Maeda , Hironobu Nagamori , Hiroshi Nakamura , Hisashi Shinkai , Yasunori Suzuki , Daisuke Takahashi , Toshio Taniguchi
发明人： Kimiya Maeda , Hironobu Nagamori , Hiroshi Nakamura , Hisashi Shinkai , Yasunori Suzuki , Daisuke Takahashi , Toshio Taniguchi
IPC分类号： A61K31/41 , A61K31/42 , C07D257/04 , C07D263/30
CPC分类号： C07D213/74 , C07C229/46 , C07C255/58 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07D231/38 , C07D239/42 , C07D249/14 , C07D257/06 , C07D261/14 , C07D263/48 , C07D271/07 , C07D271/10 , C07D275/02
摘要： A dibenzylamine compound represented by the formula (1) wherein R1 and R2 are each a C1-6 allyl group optionally substituted by halogen atoms and the like; R3, R4 and R5 are each a hydrogen atom, a halogen atom and the like, or R3 and R4 may form, together with carbon atoms bonded thereto, a homocyclic or heterocyclic ring optionally having substituent(s); A is —N(R7)(R8) and the like; ring B is an aryl group or a heterocyclic residue; R6 is a hydrogen atom, a halogen atom, a nitro group, a C1-6 allyl group and the like; n is an integer of 1 to 3, a prodrug thereof and a pharmaceutically acceptable salt thereof show selective and potent CETP inhibitory activity, and therefore, they can be provided as therapeutic or prophylactic agents for hyperlipidemia or arteriosclerosis and the like.
摘要翻译：由式（1）表示的二苄胺化合物，其中R 1和R 2各自为任选被卤素原子等取代的C 1-6烯丙基; R 3，R 4和R 5各自为氢原子，卤素原子等，或者R 3和R 4可以与其键合的碳原子一起形成任选具有取代基的双环或杂环; A是-N（R 7）（R 8）等; 环B是芳基或杂环残基; R6是氢原子，卤素原子，硝基，C1-6烯丙基等; n为1〜3的整数，其前药及其药学上可接受的盐具有选择性且有效的CETP抑制活性，因此可作为高脂血症或动脉硬化等的治疗剂或预防剂使用。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式